These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

471 related articles for article (PubMed ID: 17662114)

  • 1. Induction of labour versus expectant monitoring in women with pregnancy induced hypertension or mild preeclampsia at term: the HYPITAT trial.
    Koopmans CM; Bijlenga D; Aarnoudse JG; van Beek E; Bekedam DJ; van den Berg PP; Burggraaff JM; Birnie E; Bloemenkamp KW; Drogtrop AP; Franx A; de Groot CJ; Huisjes AJ; Kwee A; le Cessie S; van Loon AJ; Mol BW; van der Post JA; Roumen FJ; Scheepers HC; Spaanderman ME; Stigter RH; Willekes C; van Pampus MG
    BMC Pregnancy Childbirth; 2007 Jul; 7():14. PubMed ID: 17662114
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induction of labour versus expectant monitoring for gestational hypertension or mild pre-eclampsia between 34 and 37 weeks' gestation (HYPITAT-II): a multicentre, open-label randomised controlled trial.
    Langenveld J; Broekhuijsen K; van Baaren GJ; van Pampus MG; van Kaam AH; Groen H; Porath M; Oudijk MA; Bloemenkamp KW; Groot CJ; van Beek E; van Huizen ME; Oosterbaan HP; Willekes C; Wijnen-Duvekot EJ; Franssen MT; Perquin DA; Sporken JM; Woiski MD; Bremer HA; Papatsonis DN; Brons JT; Kaplan M; Nij Bijvanck BW; Mol BW;
    BMC Pregnancy Childbirth; 2011 Jul; 11():50. PubMed ID: 21736705
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction of labour versus expectant monitoring for gestational hypertension or mild pre-eclampsia after 36 weeks' gestation (HYPITAT): a multicentre, open-label randomised controlled trial.
    Koopmans CM; Bijlenga D; Groen H; Vijgen SM; Aarnoudse JG; Bekedam DJ; van den Berg PP; de Boer K; Burggraaff JM; Bloemenkamp KW; Drogtrop AP; Franx A; de Groot CJ; Huisjes AJ; Kwee A; van Loon AJ; Lub A; Papatsonis DN; van der Post JA; Roumen FJ; Scheepers HC; Willekes C; Mol BW; van Pampus MG;
    Lancet; 2009 Sep; 374(9694):979-988. PubMed ID: 19656558
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immediate delivery versus expectant monitoring for hypertensive disorders of pregnancy between 34 and 37 weeks of gestation (HYPITAT-II): an open-label, randomised controlled trial.
    Broekhuijsen K; van Baaren GJ; van Pampus MG; Ganzevoort W; Sikkema JM; Woiski MD; Oudijk MA; Bloemenkamp KW; Scheepers HC; Bremer HA; Rijnders RJ; van Loon AJ; Perquin DA; Sporken JM; Papatsonis DN; van Huizen ME; Vredevoogd CB; Brons JT; Kaplan M; van Kaam AH; Groen H; Porath MM; van den Berg PP; Mol BW; Franssen MT; Langenveld J;
    Lancet; 2015 Jun; 385(9986):2492-501. PubMed ID: 25817374
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Caesarean section rates and adverse neonatal outcomes after induction of labour versus expectant management in women with an unripe cervix: a secondary analysis of the HYPITAT and DIGITAT trials.
    Bernardes TP; Broekhuijsen K; Koopmans CM; Boers KE; van Wyk L; Tajik P; van Pampus MG; Scherjon SA; Mol BW; Franssen MT; van den Berg PP; Groen H
    BJOG; 2016 Aug; 123(9):1501-8. PubMed ID: 27173131
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management of late preterm and early-term pregnancies complicated by mild gestational hypertension/pre-eclampsia.
    Sibai BM
    Semin Perinatol; 2011 Oct; 35(5):292-6. PubMed ID: 21962629
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Should cervical favourability play a role in the decision for labour induction in gestational hypertension or mild pre-eclampsia at term? An exploratory analysis of the HYPITAT trial.
    Tajik P; van der Tuuk K; Koopmans CM; Groen H; van Pampus MG; van der Berg PP; van der Post JA; van Loon AJ; de Groot CJ; Kwee A; Huisjes AJ; van Beek E; Papatsonis DN; Bloemenkamp KW; van Unnik GA; Porath M; Rijnders RJ; Stigter RH; de Boer K; Scheepers HC; Zwinderman AH; Bossuyt PM; Mol BW
    BJOG; 2012 Aug; 119(9):1123-30. PubMed ID: 22703475
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of Hypertension and Preeclampsia Intervention Trial At Near Term-I (HYPITAT-I) on obstetric management and outcome in The Netherlands.
    de Sonnaville CMW; Hukkelhoven CW; Vlemmix F; Groen H; Schutte JM; Mol BW; van Pampus MG
    Ultrasound Obstet Gynecol; 2020 Jan; 55(1):58-67. PubMed ID: 31486156
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of the HYPITAT trial on doctors' behaviour and prevalence of eclampsia in the Netherlands.
    van der Tuuk K; Koopmans CM; Groen H; Mol BW; van Pampus MG;
    BJOG; 2011 Dec; 118(13):1658-60. PubMed ID: 21985398
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neonatal developmental and behavioral outcomes of immediate delivery versus expectant monitoring in mild hypertensive disorders of pregnancy: 2-year outcomes of the HYPITAT-II trial.
    Zwertbroek EF; Franssen MTM; Broekhuijsen K; Langenveld J; Bremer H; Ganzevoort W; van Loon AJ; van Pampus MG; Rijnders RJP; Sikkema MJ; Scherjon SA; Woiski MD; Mol BWJ; van Baar AL; Groen H;
    Am J Obstet Gynecol; 2019 Aug; 221(2):154.e1-154.e11. PubMed ID: 30940558
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An economic analysis of induction of labour and expectant monitoring in women with gestational hypertension or pre-eclampsia at term (HYPITAT trial).
    Shennan A; Hezelgrave N
    BJOG; 2010 Dec; 117(13):1575-6. PubMed ID: 21125706
    [No Abstract]   [Full Text] [Related]  

  • 12. Management of preeclampsia.
    Dekker GA
    Pregnancy Hypertens; 2014 Jul; 4(3):246-7. PubMed ID: 26104648
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Which intrauterine growth restricted fetuses at term benefit from early labour induction? A secondary analysis of the DIGITAT randomised trial.
    Tajik P; van Wyk L; Boers KE; le Cessie S; Zafarmand MH; Roumen F; van der Post JA; Porath M; van Pampus MG; Spaanderdam ME; Kwee A; Duvekot JJ; Bremer HA; Delemarre FM; Bloemenkamp KW; de Groot CJ; Willekes C; van Lith JM; Bossuyt PM; Mol BW; Scherjon SA;
    Eur J Obstet Gynecol Reprod Biol; 2014 Jan; 172():20-5. PubMed ID: 24192662
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Health-related quality of life after induction of labor versus expectant monitoring in gestational hypertension or preeclampsia at term.
    Bijlenga D; Koopmans CM; Birnie E; Mol BW; van der Post JA; Bloemenkamp KW; Scheepers HC; Willekes C; Kwee A; Heres MH; Van Beek E; Van Meir CA; Van Huizen ME; Van Pampus MG; Bonsel GJ
    Hypertens Pregnancy; 2011; 30(3):260-74. PubMed ID: 21740249
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Disproportionate Intrauterine Growth Intervention Trial At Term: DIGITAT.
    Boers KE; Bijlenga D; Mol BW; LeCessie S; Birnie E; van Pampus MG; Stigter RH; Bloemenkamp KW; van Meir CA; van der Post JA; Bekedam DJ; Ribbert LS; Drogtrop AP; van der Salm PC; Huisjes AJ; Willekes C; Roumen FJ; Scheepers HC; de Boer K; Duvekot JJ; Thornton JG; Scherjon SA
    BMC Pregnancy Childbirth; 2007 Jul; 7():12. PubMed ID: 17623077
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Maternal and perinatal outcome in pregnancies complicated with hypertensive disorder of pregnancy: a seven year experience of a tertiary care center.
    Yücesoy G; Ozkan S; Bodur H; Tan T; Calişkan E; Vural B; Corakçi A
    Arch Gynecol Obstet; 2005 Nov; 273(1):43-9. PubMed ID: 15834580
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of labour or expectant monitoring in hypertensive pregnancy disorders at term: do women's postpartum cardiovascular risk factors differ between the two strategies?
    Hermes W; Koopmans CM; van Pampus MG; Franx A; Bloemenkamp KW; van der Post J; Porath M; Tamsma JT; Mol BW; de Groot CJ
    Eur J Obstet Gynecol Reprod Biol; 2013 Nov; 171(1):30-4. PubMed ID: 24011382
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction of labour at 41 weeks versus expectant management and induction of labour at 42 weeks (SWEdish Post-term Induction Study, SWEPIS): multicentre, open label, randomised, superiority trial.
    Wennerholm UB; Saltvedt S; Wessberg A; Alkmark M; Bergh C; Wendel SB; Fadl H; Jonsson M; Ladfors L; Sengpiel V; Wesström J; Wennergren G; Wikström AK; Elden H; Stephansson O; Hagberg H
    BMJ; 2019 Nov; 367():l6131. PubMed ID: 31748223
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Study protocol of SWEPIS a Swedish multicentre register based randomised controlled trial to compare induction of labour at 41 completed gestational weeks versus expectant management and induction at 42 completed gestational weeks.
    Elden H; Hagberg H; Wessberg A; Sengpiel V; Herbst A; Bullarbo M; Bergh C; Bolin K; Malbasic S; Saltvedt S; Stephansson O; Wikström AK; Ladfors L; Wennerholm UB
    BMC Pregnancy Childbirth; 2016 Mar; 16():49. PubMed ID: 26951777
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction of labour versus expectant management in women with preterm prelabour rupture of membranes between 34 and 37 weeks (the PPROMEXIL-trial).
    van der Ham DP; Nijhuis JG; Mol BW; van Beek JJ; Opmeer BC; Bijlenga D; Groenewout M; Arabin B; Bloemenkamp KW; van Wijngaarden WJ; Wouters MG; Pernet PJ; Porath MM; Molkenboer JF; Derks JB; Kars MM; Scheepers HC; Weinans MJ; Woiski MD; Wildschut HI; Willekes C
    BMC Pregnancy Childbirth; 2007 Jul; 7():11. PubMed ID: 17617892
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.